Company signals · MedTech
Stryker
2 signals in the current window, with MitchelLake's leadership read on each.
Last updated
Market context: The wider read — a Talent Market Index of 111.1 (Hot), up 5.2 month-on-month — shows Asia signal flow rising (+3.7pts).
Stryker: 2 signals in the last 90 days — above the MedTech median of 1 across 21 tracked companies; 0.2% of MitchelLake's Asia signal flow; 2 tracked across 12 days.
Signals at Stryker
Product Launch
OceaniaStryker launched TPX HD, a new small bone power tool for orthopaedic surgery supporting complex procedures including total joint revisions, minimally invasive surgery, and oral maxillofacial operations
Leadership read: Product momentum tends to widen medtech product and commercial leadership bench strength.
curated · 2026-06-03 · context →
Geographic Expansion
AsiaStryker has established APAC operations with dedicated VP and General Manager role, indicating significant regional investment in medical technologies
Leadership read: Market entry of this kind typically deepens demand for medtech leadership bench strength in the region over the following 12–18 months.
curated · 2026-05-22 · context →
MitchelLake in this thematic
More signals across MedTech
Geographic Expansion · Asia
HistoSonics →HistoSonics received regulatory approval from Taiwan's FDA for its Edison Histotripsy System, marking a significant step in expansion into Asia
Partnership · Asia
ZEISS Medical Technology →ZEISS Medical Technology signed a strategic agreement with Aier Eye Hospital Group for purchase and installation of 25 ZEISS VISUMAX 800 femtosecond lasers across multiple locations
Geographic Expansion · Oceania
Dedalus →Dedalus is expanding its diagnostic imaging portfolio into Australia and has appointed a senior business lead to drive the initiative
Partnership · Americas
Olympus Corporation →Olympus Corporation announced a 3-year reseller agreement in May 2026 making First Nation Group an authorized Service-Disabled Veteran-Owned Small Business reseller. This partnership provides federal healthcare providers streamlined access to Olympus capital equipment and single-use medical devices across gastroenterology, urology, respiratory and surgical specialties.
Leadership Change · Americas
Illumina →Illumina appoints Daniel M. Skovronsky, Chief Scientific and Product Officer at Eli Lilly and President of Lilly Research Laboratories, to its Board of Directors, effective June 16, 2026.
Intelligence powered by Autonodal ↗